Form 15-12G - Securities registration termination [Section 12(g)]
04 Outubro 2023 - 4:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-39976
Lucira Health, Inc.
(Exact name of registrant as specified in its charter)
1315 63rd Street
Emeryville, CA 94608
(814) 574-1546
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, par value $0.001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1) |
|
☐ |
Rule 12g-4(a)(2) |
|
☐ |
Rule 12h-3(b)(1)(i) |
|
☐ |
Rule 12h-3(b)(1)(ii) |
|
☐ |
Rule 15d-6 |
|
☒ |
Rule 15d-22(b) |
|
☐ |
Approximate number of holders of record as of the certification or notice date: 0
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Lucira Health, Inc. has caused this certification/notice to be signed on
its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
LUCIRA HEALTH, INC. |
|
|
|
|
Date: October 4, 2023 |
|
|
|
By: |
|
/s/ Richard Narido |
|
|
|
|
Name: |
|
Richard Narido |
|
|
|
|
Title: |
|
Chief Financial Officer |
Lucira Health (CE) (USOTC:LHDXQ)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Lucira Health (CE) (USOTC:LHDXQ)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Lucira Health Inc (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Lucira Health Inc (CE)